Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 4/2023

23.06.2023 | Original Article

Sociodemographic and Clinical Profile of Oral Submucous Fibrosis

verfasst von: Nitin Deosthale, Mateen Khursheed, Samir Choudhary, Sonali Prabhakar Khadakkar, Chaitrika Nagwekar, Harshawardhan More, Disha Amar Methwani

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Background: Oral Submucous Fibrosis is a pre-cancerous, progressive condition caused by gutkha, areca nut consumption which is characterized by limited mouth opening, burning pain inoral cavity, stiffness and blanching of oral mucosa. Aim: To study sociodemographic characters and clinical profile of Oral Submucous Fibrosis and to assess the association of duration of adverse habits with clinical staging of Oral Submucous Fibrosis. Methodology: This cross-sectional study of 70 clinically diagnosed cases of oral submucous fibrosis was carried out at the Tertiary Health Care Centre in Central India. Over the course of two years, demographic and clinical information, including specifics on addiction and its duration, was gathered. On the basis of symptoms, the presence of palpable fibrous bands, and measuring mouth opening, clinical staging was carried out. Results: The average age of the patients in the study was 33.2 ± 12.66 years with Male female ratio of 3:1. Significantly higher proportion of patients belonged to low socioeconomic status. The maximum number of patients were seen in stage III (62.86%) followed by Stage II (21.43%) and subjects who had the adverse habits for a period of 5 to 10 years had more severe OSMF. Conclusion: In the present study, frequency of OSMF was more in young age group and in males. There was higher frequency of disease in lower socioeconomic status. Longer duration addiction was highly associated with severity of clinical stage of OSMF.
Literatur
1.
Zurück zum Zitat Das M, Manjunath C, Srivastava A et al (2017) Epidemiology of oral submucous fibrosis: a review. Int J Oral Health Med Res 3(6):126–129 Das M, Manjunath C, Srivastava A et al (2017) Epidemiology of oral submucous fibrosis: a review. Int J Oral Health Med Res 3(6):126–129
2.
Zurück zum Zitat Pindborg JJ, Sirsat SM Oral submucous fibrosis (1996). Oral Surg Oral Med Oral Pathol 22:764–79 Pindborg JJ, Sirsat SM Oral submucous fibrosis (1996). Oral Surg Oral Med Oral Pathol 22:764–79
3.
Zurück zum Zitat Rajendran R (1994) Oral submucous fibrosis: etiology, pathogenesis, and future research. Bull World Health Organ 72:985–996PubMedPubMedCentral Rajendran R (1994) Oral submucous fibrosis: etiology, pathogenesis, and future research. Bull World Health Organ 72:985–996PubMedPubMedCentral
4.
Zurück zum Zitat Tanwir F, Akhlaq H (2011) Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran J Pathol. 2011;6:165–172 Tanwir F, Akhlaq H (2011) Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran J Pathol. 2011;6:165–172
6.
Zurück zum Zitat Mathew P, Austin RD, Varghese SS, Kumar M (2014) Role of areca nut and its commercial products in oral submucous fibrosis-a review. J Adv Med Dent Sci Res 2:192–200 Mathew P, Austin RD, Varghese SS, Kumar M (2014) Role of areca nut and its commercial products in oral submucous fibrosis-a review. J Adv Med Dent Sci Res 2:192–200
7.
Zurück zum Zitat Khanna JN, Andrade NN (1995) Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 24(6):433–439CrossRefPubMed Khanna JN, Andrade NN (1995) Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 24(6):433–439CrossRefPubMed
8.
Zurück zum Zitat Gunjan K, Dash P, Patnaik J, Pany G (2022) Socioeconomic status scale-modified kuppuswamy scale for the year 2022. Int J Comm Dent 10(1):1–6CrossRef Gunjan K, Dash P, Patnaik J, Pany G (2022) Socioeconomic status scale-modified kuppuswamy scale for the year 2022. Int J Comm Dent 10(1):1–6CrossRef
9.
Zurück zum Zitat Pillai R, Balaram P (1992) Pathogenesis of oral submucous fibrosis, relationship to risk factors associated with cancer. Cancer 69:2011–2020CrossRefPubMed Pillai R, Balaram P (1992) Pathogenesis of oral submucous fibrosis, relationship to risk factors associated with cancer. Cancer 69:2011–2020CrossRefPubMed
10.
Zurück zum Zitat Memon AB, Rahman AAU, Channar KA, Zafar MS, Kumar N (2022) Evaluating the oral-health-related quality of life of oral Submucous Fibrosis Patients before and after treatment using the OHIP-14 Tool. Int J Environ Res Public Health 19(3):1821CrossRefPubMedPubMedCentral Memon AB, Rahman AAU, Channar KA, Zafar MS, Kumar N (2022) Evaluating the oral-health-related quality of life of oral Submucous Fibrosis Patients before and after treatment using the OHIP-14 Tool. Int J Environ Res Public Health 19(3):1821CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Munde A, Nayak P, Mishra S, Karle R, Farooqui A, Sawade R et al (2021) Demographic and clinical Profile of oral Submucous fibrosis: a retrospective study. J Pharm Res Int 33(56A):308–317CrossRef Munde A, Nayak P, Mishra S, Karle R, Farooqui A, Sawade R et al (2021) Demographic and clinical Profile of oral Submucous fibrosis: a retrospective study. J Pharm Res Int 33(56A):308–317CrossRef
12.
Zurück zum Zitat Biradar SB, Munde AD, Biradar BC, Shaik SS, Mishra S (2018) Oral submucous fibrosis: a clinico-histopathological correlational study. J Can Res Ther 14:597–603CrossRef Biradar SB, Munde AD, Biradar BC, Shaik SS, Mishra S (2018) Oral submucous fibrosis: a clinico-histopathological correlational study. J Can Res Ther 14:597–603CrossRef
13.
Zurück zum Zitat Hosein M, Mohiuddin S, Fatima N (2015) Association between Grading of oral Submucous Fibrosis with frequency and consumption of Areca Nut and its derivatives in a wide Age Group: a multi-centric Cross Sectional Study from Karachi, Pakistan. J Cancer Prev 20(3):216–222CrossRefPubMedPubMedCentral Hosein M, Mohiuddin S, Fatima N (2015) Association between Grading of oral Submucous Fibrosis with frequency and consumption of Areca Nut and its derivatives in a wide Age Group: a multi-centric Cross Sectional Study from Karachi, Pakistan. J Cancer Prev 20(3):216–222CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Pindborg JJ, Chawla TN, Srivastara AN, Gupta PD (1972) Clinical aspects of oral submucous fibrosis. Acta Odontol Scand 22:679–691CrossRef Pindborg JJ, Chawla TN, Srivastara AN, Gupta PD (1972) Clinical aspects of oral submucous fibrosis. Acta Odontol Scand 22:679–691CrossRef
15.
Zurück zum Zitat Shiau YY, Kwan HW (1079) Submucous Fibrosis in Taiwan. Oral Surg 47:453–457CrossRef Shiau YY, Kwan HW (1079) Submucous Fibrosis in Taiwan. Oral Surg 47:453–457CrossRef
16.
Zurück zum Zitat Ramanathan K (1981) OSMF-An alternative hypothesis as to its causes. Med J Malaysia 36:243–245PubMed Ramanathan K (1981) OSMF-An alternative hypothesis as to its causes. Med J Malaysia 36:243–245PubMed
17.
Zurück zum Zitat Panda S, Panda BK, Pattnaik B, Naik C, Dany SS, Avijeeta A (2020) Prevalence of oral submucous fibrosis in a tertiary care hospital of Odisha – a cross-sectional study. J Evid Based Med Healthc 7(49):2903–2906CrossRef Panda S, Panda BK, Pattnaik B, Naik C, Dany SS, Avijeeta A (2020) Prevalence of oral submucous fibrosis in a tertiary care hospital of Odisha – a cross-sectional study. J Evid Based Med Healthc 7(49):2903–2906CrossRef
18.
Zurück zum Zitat Angadi PV, Rekha KP (2011) Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians. Oral Maxillofac Surg 15(1):15–19CrossRefPubMed Angadi PV, Rekha KP (2011) Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians. Oral Maxillofac Surg 15(1):15–19CrossRefPubMed
19.
Zurück zum Zitat Nanavati S, Nanavati P, Nanavati M (2015) Clinico-pathological study of 170 cases of oral sub-mucous fibrosis. Int J Sci Stud 3(9):137–144 Nanavati S, Nanavati P, Nanavati M (2015) Clinico-pathological study of 170 cases of oral sub-mucous fibrosis. Int J Sci Stud 3(9):137–144
20.
Zurück zum Zitat Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN (2007) Oral sub mucosa fibrosis:study of 1000 cases from central India. J Oral Path Med 36;12 – 7. Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN (2007) Oral sub mucosa fibrosis:study of 1000 cases from central India. J Oral Path Med 36;12 – 7.
21.
Zurück zum Zitat Kumar S (2016) Oral submucous fibrosis: a demographic study. J Indian Acad Oral Med Radiol 28:124–128CrossRef Kumar S (2016) Oral submucous fibrosis: a demographic study. J Indian Acad Oral Med Radiol 28:124–128CrossRef
22.
Zurück zum Zitat Bhatta R, Pyakurel M (2014) Clinical Profile of oral submucous fibrosis. Nepal J ENT Head Neck Surg 5(1):5–7CrossRef Bhatta R, Pyakurel M (2014) Clinical Profile of oral submucous fibrosis. Nepal J ENT Head Neck Surg 5(1):5–7CrossRef
25.
Zurück zum Zitat Rajendran R, Karunakaran A (2002) Further on the causation of oral submucous fibrosis. Indian J Dent Res 13:74–82PubMed Rajendran R, Karunakaran A (2002) Further on the causation of oral submucous fibrosis. Indian J Dent Res 13:74–82PubMed
Metadaten
Titel
Sociodemographic and Clinical Profile of Oral Submucous Fibrosis
verfasst von
Nitin Deosthale
Mateen Khursheed
Samir Choudhary
Sonali Prabhakar Khadakkar
Chaitrika Nagwekar
Harshawardhan More
Disha Amar Methwani
Publikationsdatum
23.06.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 4/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-04004-9

Weitere Artikel der Ausgabe 4/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 4/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.